{
  "thread": {
    "uuid": "8ee856cb2df14687d9c547768a320c7626514fdd",
    "url": "https://finance.sina.com.cn/money/fund/etf/2025-12-25/doc-inhcywam3466898.shtml",
    "site_full": "finance.sina.com.cn",
    "site": "sina.com.cn",
    "site_section": "https://finance.sina.com.cn/stock/?wm=22713398",
    "site_categories": [
      "tech",
      "top_news_hk",
      "top_news_sg",
      "top_news_tw",
      "top_news"
    ],
    "section_title": "股票首页_新浪财经_新浪网",
    "site_title": "æ°æµªè´¢ç»_éèä¿¡æ¯æå¡å",
    "title": "长城基金龙宇飞：2026年AI医疗有望将迎来两大催化_新浪财经_新浪网",
    "title_full": "长城基金龙宇飞：2026年AI医疗有望将迎来两大催化_新浪财经_新浪网",
    "published": "2025-12-25T08:27:00.000+02:00",
    "replies_count": 0,
    "participants_count": 1,
    "site_type": "news",
    "country": "CN",
    "main_image": "",
    "performance_score": 0,
    "domain_rank": 548,
    "domain_rank_updated": "2025-12-21T23:00:00.000+02:00",
    "licensing_agency": [],
    "social": {
      "facebook": {
        "likes": 0,
        "comments": 0,
        "shares": 0
      },
      "vk": {
        "shares": 0
      }
    }
  },
  "uuid": "8ee856cb2df14687d9c547768a320c7626514fdd",
  "url": "https://finance.sina.com.cn/money/fund/etf/2025-12-25/doc-inhcywam3466898.shtml",
  "ord_in_thread": 0,
  "author": "新浪基金",
  "published": "2025-12-25T08:27:00.000+02:00",
  "title": "长城基金龙宇飞：2026年AI医疗有望将迎来两大催化_新浪财经_新浪网",
  "text": "近日，长城基金举办了2026年度投资策略会，长城消费增值基金经理龙宇飞在会上就医药产业投资领域的热门问题展开了深度探讨。\n　　当下，医药产业步入创新突破叠加技术融合的关键期，投资逻辑也在重塑。\n　　龙宇飞认为，唯一不变的就是变化本身，医药行业核心竞争力的标准在持续演进：10多年前主要比拼商业化能力，5-10年前转向产品力，如今则要求研发与商业化双优。站在当前时点，全球进入新一轮科技升级浪潮，能否拥抱新的生产力工具或产业升级方向，并将其深度融合到商业模式与研发中，将成为下一轮竞争的关键。\n　　展望2026年医药行业投资，龙宇飞认为创新药和AI医疗两大方向有望兼具行业趋势和股价趋势。\n　　关于AI医疗，龙宇飞表示，明年AI医疗有望将迎来两大催化：\n　　一是政策利好。前不久卫健委等五部委出台《关于促进和规范“人工智能+医疗卫生”应用发展的实施意见》，明确要求到2027年形成一批临床专病专科垂直大模型和智能体应用。目前仅剩2026-2027两年窗口期，叠加财政预算资金的跟进支持，2026年行业有望迎来爆发式增长。\n　　二是技术驱动。龙宇飞认为，任何一轮大的产业革命的规律实际上都是底座行业或基础设施率先受益，再渗透到各个行业。今年AI医疗已完成初步导入，随着国内算力模型能力的不断提升，应用端很可能出现上台阶式的发展，形成飞轮效应，推动医院与患者双向需求增长，复制医疗信息化从逐步渗透到效率大幅提升的发展路径。\n　　免责声明：本通讯所载信息来源于本公司认为可靠的渠道和研究员个人判断，但本公司不对其准确性或完整性提供直接或隐含的声明或保证。此通讯并非对相关证券或市场的完整表述或概括，任何所表达的意见可能会更改且不另外通知。此通讯不应被接收者作为对其独立判断的替代或投资决策依据。本公司或本公司的相关机构、雇员或代理人不对任何人使用此全部或部分内容的行为或由此而引致的任何损失承担任何责任。未经长城基金管理有限公司事先书面许可，任何人不得将此报告或其任何部分以任何形式进行派发、复制、转载或发布，且不得对本通讯进行任何有悖原意的删节或修改。基金管理人提醒，每个公民都有举报洗钱犯罪的义务和权利。每个公民都应严格遵守反洗钱的相关法律、法规。基金有风险，投资需谨慎。\nMACD金叉信号形成，这些股涨势不错！",
  "highlightText": "",
  "highlightTitle": "",
  "highlightThreadTitle": "",
  "language": "chinese",
  "sentiment": "positive",
  "categories": [
    "Health",
    "Science and Technology"
  ],
  "topics": [
    "Health->health care approach",
    "Health->medical condition",
    "Science and Technology->medical research",
    "Science and Technology->biomedical science",
    "Science and Technology->information technology and computer science"
  ],
  "ai_allow": true,
  "has_canonical": false,
  "breaking": true,
  "webz_reporter": false,
  "external_links": [
    "https://finance.sina.cn/app/sfa_macd.shtml?source=pccj",
    "https://www.finance.sina.cn/app/sfa_macd.shtml?source=pccj",
    "https://finance.sina.cn/app/sfa_macd.shtml"
  ],
  "external_images": [],
  "internal_images": [],
  "entities": {
    "persons": [],
    "locations": [],
    "organizations": []
  },
  "syndication": {
    "syndicated": null,
    "syndicate_id": null,
    "first_syndicated": false
  },
  "trust": {
    "categories": [],
    "top_news": [
      "top_news_hk",
      "top_news_sg",
      "top_news_tw",
      "top_news"
    ],
    "bias": null,
    "source": {
      "type": null,
      "city": null,
      "state": null,
      "country": null,
      "domain_type": null,
      "agency": null,
      "organization_name": null
    }
  },
  "rating": null,
  "crawled": "2025-12-25T08:31:25.348+02:00",
  "updated": "2025-12-26T09:04:42.000+02:00"
}